OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. West on ALK-NSCLC Crizotinib Survival Benefit

June 30th 2011

Dr. H. Jack West from Swedish Cancer Institute Discusses ALK-NSCLC Crizotinib Survival Benefit

Dr. Schuchter Limits BRAF Testing to Advanced Melanoma

June 30th 2011

Dr. Lynn Schuchter chief of Hematology Oncology at Penn Medicine Reserves BRAF Testing for Advanced Melanoma

Dr. Scher on Using the Circulating Tumor Cells Test

June 30th 2011

Dr. Howard Scher from MSKCC on Using the Circulating Tumor Cells Test

Dr. Vogelzang Discusses Cabozantinib's Dose Size

June 29th 2011

Dr. NJ Vogelzang from the Comprehensive Cancer Centers of Nevada Discusses Cabozantinib's Dose Size

Dr. Cella on Patient Reported Data's Cost Effectiveness

June 29th 2011

Dr. David Cella from Northwestern University Feinberg School of Medicine on Quality of Life Assessments' Cost Effectiveness

Dr. Scher on the Future of the Circulating Tumor Cell Test

June 28th 2011

Dr. Howard Scher from Memorial Sloan-Kettering on the Future of the Circulating Tumor Cell Test

Donna Berry on Prostate Cancer Patients' Challenges

June 28th 2011

Donna Berry on the Challenges Patients With Prostate Cancer Face

Dr. Kris Discusses Tests Available for Lung Cancer

June 28th 2011

Dr. Kris from Memorial Sloan-Kettering Discusses Tests Available for Lung Cancer

Dr. Schuchter on Testing for a BRAF Mutation in Melanoma

June 27th 2011

Dr. Schuchter chief of Hematology Oncology at Penn Medicine on Testing for a BRAF Mutation in Melanoma

Dr. Rini on the Axitinib and Sorafenib Trial Hazard Ratio

June 27th 2011

Dr. Brian Rini from the Cleveland Clinic Taussig Cancer Institute on the Axitinib and Sorafenib Trial Hazard Ratio

Dr. Scher on Circulating Tumor Cells in Prostate Cancer

June 27th 2011

Dr. Howard Scher from Memorial Sloan-Kettering on Circulating Tumor Cells in Prostate Cancer

Dr. Rini on the Results From His Axitinib and Sorafenib Trial

June 24th 2011

Dr. Brian Rini from the Cleveland Clinic Taussig Cancer Institute on the Results From His Axitinib and Sorafenib Trial

Dr. Smith Discusses Lymphoma in the Elderly

June 24th 2011

Dr. Sonali Smith director Lymphoma Program at the University of Chicago Medical Center Discusses Lymphoma in the Elderly

Dr. Cella on the Increase in Quality of Life Assessments

June 24th 2011

Dr. David Cella from Northwestern University Feinberg School of Medicine Explains the Increase in Quality of Life Assessments

Dr. Scher Discusses Circulating Tumor Cells

June 23rd 2011

Dr. Howard Scher form Memorial Sloan-Kettering Cancer Center Discusses Circulating Tumor Cells

Dr. Infante on the Next Step in Melanoma Research

June 23rd 2011

Dr. Jeffrey Infante from Sarah Cannon Research Institute on the Next Step in Melanoma Research

Dr. Kris Discusses the Pemetrexed Trial Results

June 23rd 2011

Dr. Mark Kris from Memorial Sloan-Kettering Cancer Center Discusses the Pemetrexed Clincal Trial Results

Dr. West Discusses Crizotinib in ALK-NSCLC Trial Results

June 23rd 2011

Dr. Jack West from the Swedish Cancer Institute Discusses Crizotinib in ALK-NSCLC Trial Results

Dr. Hoos on a Possible Successor Drug to Ipilimumab

June 22nd 2011

Dr. Axel Hoos Medical Lead in Immunology/Oncology at Bristol-Myers Squibb on a Possible Successor Drug to Ipilimumab

Dr. Vogelzang Describes Cabozantinib's Side Effects

June 21st 2011

Dr. Nicholas Vogelzang from the Comprehensive Cancer Centers of Nevada Describes Cabozantinib's side effects